news
Pricing dispute over cystic fibrosis drug Orkambi continues in the UK
Campaigners call for UK Government to intervene on pricing dispute over cystic fibrosis drug Orkambi...
List view / Grid view
Drug Markets
news
Cancer drug with accelerated approval fails Phase III trial
Results did not confirm the clinical benefit of Lartruvo in combination with doxorubicin compared to doxorubicin alone…
news
Generic version of seizure drug Sabril gets FDA approval
A generic version of the seizure drug Sabril (vigabatrin) has been approved by the FDA...
news
Oversight committee launches sweeping drug price investigation
Chairman of the Committee on Oversight and Reform sends detailed requests to 12 pharmaceutical companies about increasing drug prices...
news
Medical marketing has ‘skyrocketed’ in the past two decades
Medical marketing increased substantially from 1997 through 2016, especially direct-to-consumer advertising for drugs and health services…
news
Pharmaceutical corridor between Hong Kong and Brussels opens
The pharma corridor between Hong Kong and Brussels Airport assures handling quality for temperature-sensitive pharmaceuticals.
news
Rising drug prices linked to older products, study finds
The rising costs of brand-name drugs is largely driven by inflation in the prices of widely used existing drugs, according to a study published in the January issue of Health Affairs...
news
MHRA announces EU exit no-deal legislative proposals
Innovators should be able to get products to the UK market as quickly and simply as possible, according to the Medicines and Healthcare products Regulatory Agency...
news
Recent BPT acquisitions
Eurofins BioPharma Product Testing expands its footprint of GMP testing laboratories with recent acquisitions, including Astellas Analytical Science Laboratories, Inc. (ASL) in Japan, PHAST Gesellschaft für Pharmazeutische Qualitätsstandards mbH (PHAST) in Germany, and Bactup in France...
whitepaper
Whitepaper: The impacts of Brexit on the bio/pharmaceutical industry
On 23 June 2016, the decision was made on the European Union referendum for the United Kingdom to withdraw from the European Union.
news
Aspirin enteric-coated tablets market report 2018-2023
A market report on the aspirin enteric-coated pharmaceutical industry outlines current trends and opportunities for growth from 2018 until 2023...
news
Most FDA required post-marketing drug studies are missing
The FDA requires drugs to be tested on children after they have been approved for adults, however two thirds of these are not happening...
news
Biomanufacturing sector set to ‘boost its efficiency’
The next five years will see game-changing improvements made in upstream, downstream and continuous bioprocessing, predicts one industry specialist...
webinar
Understanding the complexities of global serialisation & traceability regulations
18 September 2018 | By Clarivate Analytics
In 2017 the WHO estimated that the counterfeit drug market represents around 10-15 percent of the pharmaceutical market worldwide, with an estimated $200bn revenue per year. Worldwide there were 3,509 pharmaceutical crime incidents in 2017, which represents an 11% increase from 2016. Most falsified medicines that reach the market do…
article
Expert view: Therapeutics trends and pharma technologies – in a state of flux
The global pharmaceutical industry has been expanding steadily at varying rates of regional growth; the pace of growth being relatively slow in the developed, matured markets but rapid in developing nations...
